Produktname:4H-Pyrimido[6,1-a]isoquinolin-4-one, 2-chloro-6,7-dihydro-9,10-dimethoxy-

IUPAC Name:2-chloro-9,10-dimethoxy-4H,6H,7H-pyrimido[4,3-a]isoquinolin-4-one

CAS:75535-96-5
Molekulare Formel:C14H13ClN2O3
Reinheit:95%+
Katalognummer:CM629267
Molekulargewicht:292.72

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM629267-1g in stock ǵǵǵ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:75535-96-5
Molekulare Formel:C14H13ClN2O3
Schmelzpunkt:-
SMILES-Code:COC1=CC2=C(C=C1OC)C1=CC(Cl)=NC(=O)N1CC2
Dichte:
Katalognummer:CM629267
Molekulargewicht:292.72
Siedepunkt:
Mdl-Nr.:
Lagerung:

Column Infos

Ensifentrine
Verona Pharma's Ensifentrine was accepted for NDA Review by FDA for chronic obstructive pulmonary disease (COPD) maintenance treatment. COPD is used to describe chronic lung diseases, encompassing emphysema, and chronic bronchitis. Phase 3 ENHANCE trials demonstrated Ensifentrine's efficacy and safety, showing significant improvements in lung function, symptom endpoints, and reducing the rate and risk of COPD exacerbations. Ensifentrine offers a novel mechanism of action. It is a dual inhibitor of phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4); it is also an activator of the cystic fibrosis transmembrane conductance regulator (CFTR).

Related Products